SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-117585
Filing Date
2022-04-25
Accepted
2022-04-25 16:19:37
Documents
5
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d429845ddef14a.htm DEF 14A 390519
2 GRAPHIC g429845g11i11.jpg GRAPHIC 54741
3 GRAPHIC g429845g22s22.jpg GRAPHIC 28859
4 GRAPHIC g429845g23s23.jpg GRAPHIC 212410
5 GRAPHIC g429845g24s24.jpg GRAPHIC 192651
  Complete submission text file 0001193125-22-117585.txt   1052050
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36332 | Film No.: 22849925
SIC: 2834 Pharmaceutical Preparations